Due Diligence’s James Fontanella-Khan, US corporate finance and deals editor, explains why established companies from brick and mortar retailers to broadcasters are taking risky bets on big acquisitions.
For the background to this video here is some additional reading from the FT archive:
Activist investors have had a quiet year, thanks to Covid-19. Even a group of investors renowned for their aggressive tactics were reluctant to publicly attack companies reeling from the impact of a global pandemic.
Why has Chinese dealmaking fizzled out? Due Diligence’s dynamic duo, James Fontanella-Khan and Arash Massoudi, answer this question in a brilliant comic book style video.
The past five years have seen over $20tn worth of M&A deals thanks to favourable market conditions, as well as resilience in the face of more recent risks.
With growing pressure on businesses to incorporate ESG in dealmaking, green bonds are proving increasingly attractive. What does growth in this method of sustainable finance mean for the investment market?
Pressure to integrate ESG factors into corporate culture means big business is shifting away from shareholder primacy and towards stakeholder capitalism. But is this move at the expense of profit?
Warren Buffett has long been admired for his investment decisions but a multibillion-dollar writedown at Kraft Heinz earlier this year has left a big blemish on his recent performance.
As technology continues to reshape large industrial companies, M&A activity in this sector is on the up. It brings with it a transformation of global workforces and a shift in national identities.
With healthcare providers turning to digital to meet consumer demands, an increasing convergence of healthcare and tech companies could restore M&A activity for 2019. But is this emerging healthtech sector immune to global uncertainty?
Why has Chinese dealmaking fizzled out? Due Diligence’s dynamic duo, James Fontanella-Khan and Arash Massoudi, answer this question in a brilliant comic book style video.
Increasing pressure on healthcare systems, massive tech growth and consumer-led demand are the perfect recipe for strong M&A activity in the emerging healthtech sector.
FT Channels, a partnership destination that combines impactful and enriching multimedia content to spark curiosity and encourage discovery. Each vertical brings expert insights from the Financial Times and our Partners into the most pressing issues of our time.
FT Big Deal is a video channel analysing the fast-moving world of M&A, illuminating the trends behind the complex global transactions and how to unlock value from acquisition deals. The channel alternates between independent reporting from FT journalists and expert commentary from law firm Baker McKenzie.
